To use all functions of this page, please activate cookies in your browser.
My watch list
my.chemeurope.com
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
65 Current news about the topic research collaborations
rss |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
Albany Molecular Research, Inc. Initiates Research Collaboration with Cubist Pharmaceuticals
21-Aug-2001
Albany Molecular Research, Inc. (Nasdaq: AMRI) today announced a drug discovery collaboration with Cubist Pharmaceuticals, Inc. (Nasdaq: CBST) through which the companies hope to identify novel anti-infective drug candidates. Under the terms of the agreement, AMRI will use its proprietary ...
Abgenix And Agensys Enter Technology License Collaboration To Discover And Develop Human Therapeutic Antibodies Against Cancer
15-Aug-2001
Abgenix, Inc. (Nasdaq: ABGX) and Agensys, Inc., a privately-held biotechnology company, announced today a research collaboration, option and license agreement under which the parties will use Abgenix’s human antibody technologies to discover and develop fully human monoclonal antibody ...
Shirley Ann Jackson, Ph.D. elected to Albany Molecular Research, Inc. Board of Directors
30-Jul-2001
Albany Molecular Research, Inc. (Nasdaq: AMRI) today announced the election of Shirley Ann Jackson, Ph.D. to its Board of Directors. This election fills a newly created position. A prominent physicist and university president, Dr. Jackson has served since 1999 as president of Rensselaer ...
Celltech and NeoGenesis Enter Research Collaboration
13-Jul-2001
Celltech Group plc (LSE; CCH; NYSE; CLL) today announced a research collaboration with NeoGenesis, Inc., a privately held biotechnology company based in Cambridge, MA, within which NeoGenesis will use its proprietary chemical genomics technology to identify and optimise new chemical compounds ...
Abgenix Reaches Milestone In Antibody Collaboration With Amgen,
11-Jul-2001
Abgenix, Inc. (NASDAQ: ABGX) today announced that Amgen Inc. (Amgen) has advanced into clinical trials a fully human antibody generated with Abgenix’s technology. This milestone triggers an undisclosed payment to Abgenix. "We are pleased with the productivity of our collaboration with Amgen, ...
Abgenix Enters Xenomouse™ Technology Collaboration With Biogen To Generate Fully Human Antibodies
15-Jun-2001
Abgenix, Inc. (Nasdaq: ABGX) today announced that it has signed a research collaboration, option and license agreement with Biogen, Inc. under which the parties will use Abgenix’s XenoMouse ™ technology to generate fully human monoclonal antibodies to up to fifteen antigen targets supplied by ...
Dow and University of Stuttgart Form Research Collaboration
15-May-2001
The Dow Chemical Company and the University of Stuttgart have announced a long-range collaborative research program targeting the improvement of environmental profiles for some plastics, more sustainable industrial processes and new biocatalytic processes to produce pharmaceuticals. Contingent ...
Innovase LLC, a Joint Venture between Dow and Diversa, Announces Research Collaboration with The Procter & Gamble Company
31-Jan-2001
Innovase LLC, a 50/50 joint venture between Diversa Corporation (Nasdaq: DVSA) and The Dow Chemical Company (NYSE: DOW), today announced the signing of a collaboration agreement with The Procter & Gamble Company (NYSE: PG). Under the terms of the agreement, Innovase will discover, optimize and ...
GPC Biotech Announces Proteomics Alliance with Aventis Pharma
20-Dec-2000
GPC Biotech AG (Frankfurt Stock Exchange: GPC), a leading genomics- and proteomics-based drug discovery company, today announced a research collaboration with Aventis Pharma Drug Innovation and Approval (Paris, France) utilizing GPC Biotech's PathCode™ technology to identify and validate ...
MorphoSys Announces Milestone
15-Dec-2000
MorphoSys AG (Neuer Markt: MOR) announced the successful installation of MorphoSys’ fully automated antibody generation system AutoCALTM at the DuPont Pharmaceuticals research facility in Wilmington, DE/USA. AutoCALTM is MorphoSys’ proprietary robotic system that allows high throughput screening ...
